# UNCY PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/UNCY
Company: Unicycive Therapeutics

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with UNCY.

## UNCY PDUFA Milestones

- 2026-06-29 — PDUFA — FDA issued a second Complete Response Letter. The CRL cited the same unresolved deficiencies at a third-party manufacturing vendor identified in the first re...
  Company: Unicycive Therapeutics
  Source: https://ir.unicycive.com/news/detail/123/unicycive-therapeutics-receives-complete-response-letter
  Event detail: https://biopharmsignal.com/pdufa-calendar/UNCY/oxylanthanum-carbonate-hyperphosphatemia-review-2.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/UNCY
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the UNCY PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with UNCY, including decision dates, application stage, and summary details when available.
### Where can I find more context for UNCY?

Use the BioPharmSignal company page for UNCY to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.